v3.26.1
Consolidated Statement Of Redeemable Noncontrolling Interest and Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares
Additional Paid in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Parent
Noncontrolling Interest
Redeemable Noncontrolling Interest
Balance at Dec. 31, 2024               $ 92
Balance at Jun. 30, 2025               103
Balance at Dec. 31, 2024 $ 8,993 $ 2 $ 2,966 $ 7,002 $ (1,174) $ 8,796 $ 197  
Balance, in shares at Dec. 31, 2024   235            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income attributable to Aptiv 382     382   382    
Other comprehensive (loss) income 461       460 460 1 13
Net income attributable to noncontrolling interest 6           6 (2)
Dividend payments of consolidated affiliates to minority shareholders 22           22  
Taxes witheld on employees' restricted share award vestings (19)   (19)     (19)    
Repurchases of ordinary shares (750) $ 0 (163) (587)   (750)    
Repurchase of ordinary shares, in shares   (18)            
Forward contracts for share repurchases 750   (750)     750    
Share-based compensation, in shares   1            
Share based compensation 71   71     71    
Balance at Jun. 30, 2025 9,872 $ 2 3,605 6,797 (714) 9,690 182  
Balance, in shares at Jun. 30, 2025   218            
Balance at Dec. 31, 2024               92
Balance at Dec. 31, 2025 102             102
Balance at Dec. 31, 2024 8,993 $ 2 2,966 7,002 (1,174) 8,796 197  
Balance, in shares at Dec. 31, 2024   235            
Balance at Dec. 31, 2025 9,397 $ 2 3,619 6,227 (641) 9,207 190  
Balance, in shares at Dec. 31, 2025   213            
Balance at Mar. 31, 2025               95
Balance at Jun. 30, 2025               103
Balance at Mar. 31, 2025 9,159 $ 2 3,372 6,598 (1,011) 8,961 198  
Balance, in shares at Mar. 31, 2025   224            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income attributable to Aptiv 393     393   393    
Other comprehensive (loss) income 298       297 297 1 9
Net income attributable to noncontrolling interest 5           5 (1)
Dividend payments of consolidated affiliates to minority shareholders 22           22  
Repurchases of ordinary shares (250)   (56) (194)   (250)    
Repurchase of ordinary shares, in shares   (6)            
Forward contracts for share repurchases 250   250     250    
Share-based compensation, in shares   0            
Share based compensation 39   39     39    
Balance at Jun. 30, 2025 9,872 $ 2 3,605 6,797 (714) 9,690 182  
Balance, in shares at Jun. 30, 2025   218            
Balance at Dec. 31, 2025 102             102
Redeemable Noncontrolling Interest                
Acquisition of redeemable noncontrolling interest (Note 16) (97)              
Balance at Jun. 30, 2026 0             0
Balance at Dec. 31, 2025 9,397 $ 2 3,619 6,227 (641) 9,207 190  
Balance, in shares at Dec. 31, 2025   213            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income attributable to Aptiv 437     437   437    
Other comprehensive (loss) income (98)       (99) (99) 1 (3)
Net income attributable to noncontrolling interest 3           3 (2)
Dividend payments of consolidated affiliates to minority shareholders 4           4  
Taxes witheld on employees' restricted share award vestings (36)   (36)     (36)    
Repurchases of ordinary shares (325) $ 0 (47) (278)   (325)    
Repurchase of ordinary shares, in shares   (5)            
Distribution of Versigent (2,598)     (2,701) 293 (2,408) (190)  
Dividend received from spin-off of Versigent 1,893     1,893   1,893    
Acquisition of redeemable noncontrolling interest (Note 16) 30   23   7 30    
Share based compensation 54   54     54    
Balance at Jun. 30, 2026 8,753 $ 2 3,613 5,578 (440) 8,753 0  
Balance, in shares at Jun. 30, 2026   208            
Balance at Mar. 31, 2026               99
Redeemable Noncontrolling Interest                
Acquisition of redeemable noncontrolling interest (Note 16) (97)              
Balance at Jun. 30, 2026 0             0
Balance at Mar. 31, 2026 9,423 $ 2 3,599 6,351 (719) 9,233 190  
Balance, in shares at Mar. 31, 2026   212            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income attributable to Aptiv 248     248   248    
Other comprehensive (loss) income (21)       (21) (21)   (1)
Net income attributable to noncontrolling interest               $ (1)
Taxes witheld on employees' restricted share award vestings (2)   (2)     (2)    
Repurchases of ordinary shares (250)   (37) (213)   (250)    
Repurchase of ordinary shares, in shares   (4)            
Distribution of Versigent (2,598)     (2,701) 293 (2,408) (190)  
Dividend received from spin-off of Versigent 1,893     1,893   1,893    
Acquisition of redeemable noncontrolling interest (Note 16) 30   23   7 30    
Share-based compensation, in shares   0            
Share based compensation 30   30     30    
Balance at Jun. 30, 2026 $ 8,753 $ 2 $ 3,613 $ 5,578 $ (440) $ 8,753 $ 0  
Balance, in shares at Jun. 30, 2026   208